Uy Ear
Stock Analyst at Mizuho
(0.65)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceutica... | Maintains: Neutral | 23 24 | 24.83 | -3.34% | 13 | Aug 7, 2025 | |
MBX MBX Biosciences | Initiates Coverage On: Outperform | 38 | 11.2 | 239.29% | 1 | Aug 5, 2025 | |
SRPT Sarepta Therapeutics | Downgrades: Neutral | 40 14 | 17.95 | -22.01% | 8 | Jul 21, 2025 | |
TECX Tectonic Therapeutic | Maintains: Outperform | 51 85 | 22.01 | 286.19% | 2 | May 15, 2025 | |
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 20 21 | 14.19 | 47.99% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 20 | 14.13 | 41.54% | 4 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 1 | 0.56 | 78.57% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 40 | 26.55 | 50.66% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 16 | 8.68 | 84.33% | 2 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 11 | 263.64% | 1 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 23 | 5.76 | 299.31% | 3 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 116 140 | 123.99 | 12.91% | 10 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 24 | 1.4 | 1614.29% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 16 | 3.65 | 338.36% | 1 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.88 | 240.91% | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 40 | 173.87 | -76.99% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 | 1.1 | 81.82% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 | 1.32 | 657.58% | 1 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | 0.98 | 206.12% | 2 | Mar 1, 2023 |